Search

everythinglearnresearchcommunity

for

Search:↓

Higher disease activity in systemic lupus erythematosus is strongly linked to more internal organ damage.

Lower GPX4 mRNA levels are linked to higher disease activity and symptoms in lupus patients.

Interest in COVID-19 hair loss increased during COVID-19 surges, especially in higher-income countries.

Some drugs may increase the risk of obstructive sleep apnea, while others like certain biologics might decrease it.

Different skin conditions show distinct types of vessel inflammation, a new quality of life index for vulval disease is reliable, a certain intrauterine system might be linked to chronic vaginal yeast infections, and oral minoxidil reduces hair loss in women.

Methylated gene parts may cause finasteride-resistance in some enlarged prostate patients.

Female pattern hair loss greatly affects quality of life, especially in younger patients, those with the condition for a long time, and those with mental health issues. A more comprehensive treatment approach is suggested.

Hair cortisol levels can show increased stress during late pregnancy but only for up to six months.

Improving artificial vascular grafts requires better materials and surface designs to reduce blood clotting and support blood vessel cell growth.

Hair and nail cells share similar proteins, indicating a common differentiation pathway.

The study found that in Latin America, ancestry varies by location, influences physical traits, and affects how people perceive their own heritage.

SKPs are similar to adult skin stem cells and could help in skin repair and hair growth.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Women with PCOS often have more belly fat and higher insulin levels, but belly fat isn't the only cause of their insulin resistance.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Dutasteride more effective for hair growth, but has more side effects than finasteride.

Genetic variation in the androgen receptor gene mainly causes early-onset hair loss, with maternal inheritance playing a key role.

Women look young for their age due to larger lips, less sun damage, and genes that prevent gray hair and wrinkles.

Electrolysis is effective for permanent hair removal, but technique is key to avoid scarring, and sometimes hormonal treatment is needed for women with hirsutism.

Eflornithine cream effectively reduces women's unwanted facial hair but hair returns if treatment stops.

Ruby laser pulses best destroy hair follicles during the growth phase and effectiveness varies with laser intensity; melanin is key for targeting, and timing treatments can improve results.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

PRP injections improve hair thickness for baldness.

Researchers found that hair shedding happens mostly when new hair is growing and involves a unique process.

Skin-derived precursors in hair follicles come from different origins but function similarly.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.